The National Institute for Health and Care Excellence has turned down the drug due to a lack of clarity over whether it ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma. The indication applies ...
PCV plus radiation improved overall and progression-free survival compared to TMZ plus radiation in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma patients. Five-year overall survival was 89% ...
A 32-year-old man living with a rare form of terminal brain cancer said he was determined to become the first person to run ...
Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative ...
NCCTG 94–72-53: Diagnostic and prognostic significance of 1p and 19q deletions in patients (pts) with low-grade oligodendroglioma and astrocytoma No significant financial relationships to disclose.
Stories by SWNS on MSN
Vice principal diagnosed with brain tumour after forgetting to pick his wife up
A vice principal was diagnosed with a rare brain tumour after he forgot to pick his wife up after work and couldn’t remember ...
NEW YORK CITY (WABC) -- Running 26.2 miles is an impressive journey in itself. Multiplying that by 300 might seem unimaginable. For Julia Khavsechko, the New York City Marathon will be her milestone ...
A MUM who couldn't sleep due to a "funny" whirring sound in her ear realised she had been hearing symptoms of her cancer after being diagnosed with a brain tumour. Denise Wingfield, 55, was initially ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...
A 31 year-old man presented with headaches and focal seizures affecting the right side of his body. Low Grade Glioma. (Left) T2-weighted axial MRI; (Middle) T1-weighted axial MRI; (Right) T1-weighted ...
A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype (CIMP) status and O 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation as assessed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback